MAIT cells egress the thymus at several maturation stages with selective capacity to seed different tissues
Immunity · 2026
DOI: 10.1016/j.immuni.2026.03.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2026. Verfasst von Rafael Almeida Paiva und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France. Electronic address: rafael.de-almeida-paiva@curie.fr. Hauptthemen laut MEDLINE: Mucosal-Associated Invariant T Cells, Thymus Gland, Natural Killer T-Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Equipex, Fondation pour la Recherche Médicale, Agence Nationale de la Recherche.
Abstract (Originalsprache)
Mucosal-associated invariant T (MAIT) and invariant natural killer T (iNKT) cells participate in tissue homeostasis and repair and in defense against pathogens. While MAIT and iNKT cells share a developmental pathway leading to the expression of effector-memory and tissue-residency programs, differences in subset proportions and tissue distribution suggest lineage-specific developmental mechanisms. We show that thymic epithelial cells contribute to MAIT but not to iNKT cell selection, which relies solely on double-positive thymocytes. Nonetheless, MAIT and iNKT cells had similar developmental kinetics and thymic residency properties. MAIT cells egressed the thymus at several developmental stages and colonized specific tissues. Semi-mature cells seeded the intestine via chemokine receptor CCR9. Thymic output during adulthood contributed to tissue MAIT and iNKT cell homeostasis. Lastly, MAIT ligands produced during colitis induced thymic MAIT17 cell expansion and migration to the colon, which suggests a feedback loop that boosts the production of MAIT cells capable of re-establishing epithelial integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France. Electronic address: rafael.de-almeida-paiva@curie.fr.
- Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.
- Cytometry Platform, CurieCore Tech, Institut Curie, 75005 Paris, France.
- INSERM ERL1305, CNRS UMR6290, Université de Rennes, Institut de Génétique & Développement, de Rennes, France.
- Centre d'Immunophénomique (CIPHE), Aix Marseille Université, INSERM, CNRS, Marseille, France.
- Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France; Laboratoire d'immunologie clinique, Institut Curie, 75005 Paris, France; Centre d'investigation Clinique en Biothérapie Gustave-Roussy Ins…
Förderung
- Equipex
- Fondation pour la Recherche Médicale
- Agence Nationale de la Recherche
- HORIZON EUROPE Framework Programme
- Institut National de la Santé et de la Recherche Médicale
- Institut Curie
- National Institutes of Health
- European Research Council
Zitieren
APA
Paiva, R. A., Brière, H., Le Gac, A. L., Darbois, A., Perrin, L., Belmellat, A., Saji, C., Furstenheim, M., Guyonnet, L., Legoux, F., Malissen, B., Salou, M., & Lantz, O. (2026). MAIT cells egress the thymus at several maturation stages with selective capacity to seed different tissues. Immunity. https://doi.org/10.1016/j.immuni.2026.03.024
Vancouver
Paiva RA, Brière H, Le Gac AL, Darbois A, Perrin L, Belmellat A, et al. MAIT cells egress the thymus at several maturation stages with selective capacity to seed different tissues. Immunity. 2026. doi:10.1016/j.immuni.2026.03.024
BibTeX
@article{Paiva2026,
author = {Paiva, Rafael Almeida and Brière, Hugues and Le Gac, Anne-Laure and Darbois, Aurélie and Perrin, Laetitia and Belmellat, Anya and Saji, Chaimae and Furstenheim, Mariela and Guyonnet, Lea and Legoux, François and Malissen, Bernard and Salou, Marion and Lantz, Olivier},
title = {MAIT cells egress the thymus at several maturation stages with selective capacity to seed different tissues},
journal = {Immunity},
year = {2026},
doi = {10.1016/j.immuni.2026.03.024}
}
EUVIMED